Nick and Chris have spent their careers working together to uncover the secrets of treatment resistance. They’re motivated by patients, their families, and loved ones. Their breakthrough occurred when they decoupled the biology of what causes cancer and what causes treatment resistance. It led them to build the ResCu System, the first cancer drug discovery system harnessing evolution to generate the missing data needed to develop Resistance Suppressing Therapy (ReST).
Our diverse team of resistance fighters is dedicated to bringing together the best minds, a spirit of collaboration, and innovative science to develop life-saving ReSTs for Cancer Patients. Our goal is to provide patients with more treatment options.
Platform Engineer II
Lead Organoid Scientist
Lead Microfluidics Bioengineer
Cancer Organoid Research Associate
Head of Business Development